Australia, Jan. 7 -- Telix Pharmaceuticals Ltd. (TLX) has reported gross short sales of 99,138 FPO shares on Jan. 3. The percent of issued capital of the company reported as short sales is 0.03 percent. The issued capital of the company is 334,724,485 shares.
Disclaimer: Curated by HT Syndication.
